Author

D. Hober

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Biela· 1 shared A. Danneels· 1 shared A. Halouani· 1 shared A. Machelart· 1 shared A. Vandeputte· 1 shared B. Deprez· 1 shared C. Moreau· 1 shared C. Piveteau· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Biela

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

S. Belouzard, A. Machelart, V. Sencio, T. Vausselin, E. Hoffmann, N. Deboosere, Y. Rouille, L. Desmarets, K. Seron, A. Danneels, C. Robil, L. Belloy, C. Moreau, C. Piveteau, A. Biela, , J. Dubuisson

This paper identifies clofoctol as an antiviral against SARS-CoV-2, showing it inhibits viral replication and reduces lung pathology in mice.

bioRxiv · Jun 30, 2021 · PreprintMicrobiology

Mechanisms of Igf2 inhibition in thymic epithelial cells infected by coxsackievirus CV-B4

H. Michaux, A. Halouani, C. Trussart, C. Renard, H. Jaïdane, H. Martens, D. Hober, V. Geenen

This study investigates how CV-B4 infection affects Igf2 transcription in thymic epithelial cells, showing decreased Igf2 isoforms and promoter activity, and links this to reduced STAT3 signaling, potentially disrupting central self-tolerance.

bioRxiv · Jan 10, 2020 · PreprintMicrobiology